SHANDONG XINHUA (00719) disclosed that its subsidiary, Shandong Xinhua Health Technology Co., Ltd., has obtained the Medical Device Registration Certificate of the People's Republic of China from the National Medical Products Administration. This authorization falls under the stringent Class III medical device category. The announcement highlights China's rapidly expanding ophthalmic care market, where sterile care solutions represent the fastest-growing segment. Such products directly address consumers' increasing demand for precise eye health management solutions. The newly approved contact lens sterile saline solution broadens the company's product offerings, providing enhanced options for customers while strengthening its competitive edge in the healthcare sector.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。